Denmark· DK-28107429325
Metolazone Abcur
A metolazone product containing metolazon, registered in Denmark by Orifarm A/S. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Metolazone is registered in 10 of 19 countries.
Countries holding a registration under ATC C03BA08 (metolazone), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Metolazone · ATC C03BA08
10 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of metolazone costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.19 in Italy to $1.25 in Switzerland — a ×6.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Metolazone · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.25
- IT Italy$0.19
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Metolazon
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- C03BA08
- ATC class
- Metolazone
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107429325
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
326 interactions on record for metolazone.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metolazone · interactions on record
326 records
- 4 severe
- 208 moderate
- 19 minor
- 91 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Aminolevulinic acidL01XD04severe
- Arsenic trioxideL01XX27severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C03BA08
Metolazone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa97b353-72c2-4305-a558-7bacd9369fa6 GET /v1/drugs/fa97b353-72c2-4305-a558-7bacd9369fa6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "5 mg",
"auth_role": "DKMA",
"dk_drugid": "28107429325",
"substance": "Metolazon",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "45926"
}See everything about metolazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.